License and Copyright© 2018 by the authors; CC BY-NC-ND license
Keywordsyttria; nanoprobes; optical imaging; magnetic resonance imaging; cytotoxicity; T1-weighted contrast agent; titanium dioxide nanoparticles; intestinal epithelial cells; inflammation; endocytosis; EGFR; ERK1/2; photodynamic therapy; optimized nano-carrier; multifunctional magnetic nanoparticle; fluence; anticancer activity; prostate cancer cell; multifunctional nanoparticle; antioxidant activity; antibacterial activity; caffeic acid; ZnO; mesoporous silica nanoparticles; drug delivery; tumor targeting; biocompatibility; holmium oxide; paramagnetic nanoparticles; T2-weighted magnetic resonance imaging; toxicity; gallium ion; apatite formation; gallium titanate; Ti metal; simulated body fluid; antibacterial; autophagy; apoptosis; glioblastoma multiforme; nanotoxicity; silica nanoparticles; SrTi1−xFexO3 thin films; sol-gel; multiferroic; leakage current; conduction mechanism; cell proliferation; bone regeneration; hyaluronate; MC3T3 cell; pattern gel; ZnO@GA; antioxidative activity; antibacterial activity; gallic acid; antibiotic resistance; methicillin-resistant Staphylococcus aureus; graphene nanomaterial; multifaceted biomedical application; coated substrate; patterned array; hybrid scaffold
Accessibility InformationWe are working as quickly as possible to make a fully accessible version of this title. Thank you for your patience.
